Résumé
Avec l’âge maternel et le tabac, l’IMC est un facteur pronostic important de la fertilité d’une femme. Chez une femme obèse, une prise en charge hygiéno-diététique préconceptionnelle doit être mise en place précocement en amont du désir de grossesse, à la fois pour améliorer la fertilité, mais aussi pour diminuer les futures complications obstétricales. En cas d’infertilité, la prise en charge d’une patiente obèse devra tenir compte de son âge et de l’association ou non à un syndrome des ovaires polykystiques (SOPK). Une perte de poids est recommandée chez une femme obèse et jeune pour rétablir des ovulations spontanées et diminuer la morbidité obstétricale. En revanche, après 35 ans, l’obtention d’une perte de poids ne doit pas retarder la prise en charge en AMP d’une infertilité. En effet, l’âge de la patiente et sa réserve ovarienne sont des éléments pronostics plus importants que l’IMC. Chez les femmes obèses de plus de 35 ans, une exigence de perte de poids serait plus dommageable que les effets délétères propres de l’obésité sur la fertilité. Par ailleurs, les données concernant l’intérêt de la chirurgie bariatrique avant AMP sont très discutées. Si l’obésité est associée à un SOPK, les mesures hygiéno-diététiques seront au coeur de la prise en charge et pourront être associées à la prescription de myo-inositol.
Abstract
With maternal age and tobacco, IMC is a significant prognostic factor for female fertility. In an obese woman, a life-style intervention program with weight loss must be set up early before the desire for pregnancy, both to improve fertility and to reduce future obstetric complications. In case of infertility, the management of an obese women depends on her age and the association or not with a Polycystic Ovary Syndrome (PCOS). Weight loss is recommended in a young obese woman to restore spontaneous ovulation and decrease obstetrical morbidity. On the other hand, after 35 years, a weight loss should not delay the management of an infertility by ART (Assisted Reproductive Treatment). Indeed, the age of the women and her ovarian reserve are much more important prognosis factors than the BMI. After 35 years, weight loss requirement to achieve could be more damaging than the BMI himself. Data on the value of bariatric surgery prior ART are still debated. If obesity is associated with PCOS, weight loss associated with a prescription of Myoinositol should be strongly encouraged.
Références
Ng M, Fleming T, Robinson M, et al (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 384:766–81
Steeg JW, van der Steures P, Eijkemans MJC, et al (2008) Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 23:324–8
Brewer CJ, Balen AH (2010) The adverse effects of obesity on conception and implantation. Reproduction. 140:347–64
AMAR A. pour la pratique clinique La prise en charge du couple infertile
projet_de_grossesse_informations_messages_de_prevention_ examens_a_proposer_-_argumentaire.pdf. (n.d.). Retrieved from http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-01/projet_de_grossesse_informations_messages_de_prevention_ examens_a_proposer_-_argumentaire.pdf
Vahratian A, Smith YR (2009) Should access to fertility-related services be conditional on body mass index? Hum Reprod. 24:1532–7
Provost MP, Acharya KS, Acharya CR, et al (2016) Pregnancy outcomes decline with increasing body mass index: analysis of 239, 127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registry. Fertil Steril. 105:663–9
Koning AMH, Mutsaerts MQ, Kuchenbecher WKH, et al (2012) Complications and outcome of assisted reproduction technologies in overweight and obese women. Hum Reprod. 27:457–67
Maheshwari A, Scotland G, Bell J, et al (2009) The direct health services costs of providing assisted reproduction services in overweight or obese women: a retrospective cross-sectional analysis. Hum Reprod. 24:633–9
Provost MP, Acharya KS, Acharya CR, et al (2016) Pregnancy outcomes decline with increasing recipient body mass index: an analysis of 22, 317 fresh donor/recipient cycles from the 2008-2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry. Fertil Steril. 105:364–8
nationalcompletfiv2014.pdf. (n.d.). Retrieved from https://www.agence-biomedecine.fr/IMG/pdf/nationalcompletfiv2014.pdf
Bhattacharya S, Campbell DM, Liston WA, Bhattacharya S (2007) Effect of Body Mass Index on pregnancy outcomes in nulliparous women delivering singleton babies. BMC Public Health. 7:168
Weiss JL, Malone FD, Emig D, et al (2004) Obesity, obstetric complications and cesarean delivery rate–a population-based screening study. American Journal of Obstetrics and Gynecology. 190:1091–7
Broekmans FJ, Soules MR, Fauser BC (2008) Ovarian Aging: Mechanisms and Clinical Consequences. Endocrine Reviews. 30:465–93
Clark AM, Thornley B, Tomlinson L, et al (1998) Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 13:1502–5
Franz MJ, VanWormer JJ, Crain AL, et al (2007) Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc, 107:1755–67
Delbaere I, Verstraelen H, Goetgeluk S, et al (2007) Pregnancy outcome in primiparae of advanced maternal age. Eur J Obstet Gynecol Reprod Biol. 135:41–6
Hook EB (1981) Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol. 58:282–5
Maheshwari A, Scotland G, Bell J, et al (2010) Direct health services costs of providing assisted reproduction services in older women. Fertility and Sterility. 93:527–36
Grodstein F, Goldman MB, Cramer DW (1994) Body Mass Index and Ovulatory Infertility. Epidemiology. 5:247–50
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report (1998) National Institutes of Health. Obes Res. 2:51S–209S
Mutsaerts MAQ, van Oers AM, Groen H, et al (2016) Randomized Trial of a Lifestyle Program in Obese Infertile Women. N. Engl. J. Med. 374:1942–53
Mutsaerts M A. Q, Kuchenbecker WKH, Mol BW, et al (2013) Dropout is a problem in lifestyle intervention programs for overweight and obese infertile women: a systematic review. Hum Reprod. 28:979–86
Oers AM, van Groen H, Mutsaerts MQ, et al (2016) Effectiveness of lifestyle intervention in subgroups of obese infertile women: a subgroup analysis of a RCT. Hum Reprod. 31:2704–13
Musella M, Milone M, Bellini M, et al (2012) Effect of bariatric surgery on obesity-related infertility. Surg Obes Relat Dis. 8:445–9
obesity_surgery_-_guidelines.pdf [Internet]. [cited 2017 Jan 16]. Available from: http://www.has-sante.fr/portail/upload/docs/application/ pdf/2010-11/obesity_surgery_-_guidelines.pdf
Merhi ZO, Minkoff H, Feldman J, et al (2008) Relationship of bariatric surgery to Müllerian-inhibiting substance levels. Fertility and Sterility. 90:221–4
Bhandari S, Ganguly I, Bhandari M, et al (2016) Effect of sleeve gastrectomy bariatric surgery-induced weight loss on serum AMH levels in reproductive aged women. Gynecol Endocrinol. 17:1–4
Christofolini J, Bianco B, Santos G, et al (2014) Bariatric surgery influences the number and quality of oocytes in patients submitted to assisted reproduction techniques. Obesity 22:939–42
Galazis N, Docheva N, Simillis C, Nicolaides KH (2014) Maternal and neonatal outcomes in women undergoing bariatric surgery: a systematic review and meta-analysis. European Eur J Obstet Gynecol Reprod Biol. 181:45–53
Kiddy DS, Sharp PS, White DM, et al (1990) Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol. 32:213–20
Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 89:505–22
Conway G, Dewailly D, Diamanti-Kandarakis E, et al (2014) The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 171:P1–29
Kiddy DS, Hamilton-Fairley D, Bush A, et al (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol. 36:105–11
Tang T, Lord JM, Norman RJ, et al (2012) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. CD003053
Palomba S, Falbo A, La Sala G (2013) Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials. BJOG. 120:267–76
Siebert TI, Viola MI, Steyn DW, Kruger TF (2012) Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis. Gynecol Obstet Invest. 73:304–13
Hashim HA (2016) Twenty years of ovulation induction with metformin for PCOS; what is the best available evidence? Reproductive BioMedicine Online. 32:44–53
Tso LO, Costello MF, Albuquerque LET, et al (2014) Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews CD006105
Facchinetti F, Bizzarri M, Benvenga S, et al (2015) Results from the International Consensus Conference on Myo-inositol and dchiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS. Eur. J. Obstet. Gynecol. Reprod. Biol. 195:72–6
Rolland AL, Dewailly D (2015) Intérêt du myo-inositol dans le syndrome des ovaires polykystiques. Médecine thérapeutique, Médecine de la reproduction, gynécologie et endocrinologie, 17:186–92
Unfer V, Carlomagno G, Dante G, Facchinetti F (2012) Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol. 28:509–15
Unfer V, Carlomagno G, Papaleo E, et al (2014) Hyperinsulinemia Alters Myoinositol to d-chiroinositol Ratio in the Follicular Fluid of Patients With PCOS. Reproductive Sciences 21:854–8
Skubleny D, Switzer NJ, Gill RS, et al (2016) The Impact of Bariatric Surgery on Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis. Obes Surg. 26:169–76
Sermondade N, Massin N, Boitrelle F, et al (2012) Sperm parameters and male fertility after bariatric surgery: three case series. Reproductive BioMedicine Online. 24:206–10
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vincentelli, C., Gaborit, B., Castera, V. et al. Prise en charge de l’infertilité chez la femme obèse. Obes 12, 186–192 (2017). https://doi.org/10.1007/s11690-017-0559-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11690-017-0559-8